XPeng G9 SUV earns 5-star safety rating from Euro NCAP

NYSE:XPEV   XPeng Inc.
Chinese electric vehicle maker, XPeng Motors (NYSE:XPEV) announced Wednesday that the international model of their XPeng G9 SUV has received a five-star 2023 safety rating from Euro NCAP.

The five-star safety rating system by Euro NCAP is designed to assist consumers, families, and businesses in easily comparing vehicles and selecting the safest option suited to their requirements. These tests, mirroring real-life road dangers, set the benchmark in Europe for thorough automotive safety evaluations.

The XPeng G9's rating acknowledges its advanced body structure and extensive passive safety features, specifically engineered to safeguard passengers during collisions. These innovations collaborate to handle crash forces, diminish impact acceleration, and decrease the likelihood of injuries to occupants.

This achievement follows XPeng's five-star safety rating for the international model of the XPeng P7 in October, marking their second five-star rating this year.

Technical Analysis
Shares of XPEV are up 4.26% in mid-day trading.
The earnings estimate for the current quarter (Dec 2023) is -$0.46 per share, which is lower than the actual earnings of -$0.39 per share in the same quarter last year3. The revenue estimate for the current quarter is $1.89 billion, which is more than double the actual revenue of $733.4 million in the same quarter last year.

The growth estimates for XPEV are negative, with a projected decline of -7.5% in earnings for the current year (2023) and a projected decline of -5.74% in earnings for the next five years (per annum).

XPEV is facing some challenges in the market, despite its strong revenue growth. The stock price may continue to fluctuate in the near term, depending on the company’s performance and the market sentiment.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Email Newsletter:

2) Text Message Notifications:

3) Telegram:

4) Follow Us on our Social Networks

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.